Cas:103321-53-5 Fmoc-Val-Cl manufacturer & supplier

We serve Chemical Name:Fmoc-Val-Cl CAS:103321-53-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Fmoc-Val-Cl

Chemical Name:Fmoc-Val-Cl
CAS.NO:103321-53-5
Synonyms:9H-Fluoren-9-ylmethyl [(2S)-1-chloro-3-methyl-1-oxo-2-butanyl]carbamate;Fmoc-L-Val-Cl;N-Fmoc-L-valine chloride;Fmoc-Val-Cl;Carbamic acid, N-[(1S)-1-(chlorocarbonyl)-2-methylpropyl]-, 9H-fluoren-9-ylmethyl ester
Molecular Formula:C20H20ClNO3
Molecular Weight:357.831
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:508.7±33.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.580
PSA:55.40000
Exact Mass:357.113159
LogP:5.16

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 9H-Fluoren-9-ylmethyl [(2S)-1-chloro-3-methyl-1-oxo-2-butanyl]carbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Carbamic acid, N-[(1S)-1-(chlorocarbonyl)-2-methylpropyl]-, 9H-fluoren-9-ylmethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9H-Fluoren-9-ylmethyl [(2S)-1-chloro-3-methyl-1-oxo-2-butanyl]carbamate Use and application,9H-Fluoren-9-ylmethyl [(2S)-1-chloro-3-methyl-1-oxo-2-butanyl]carbamate technical grade,usp/ep/jp grade.


Related News: In his new role, Grégoire will ensure alignment between NOVA’s business strategy, operations and growth objectives, as well as leading the Modelling and Simulation (M&S) team as NOVA embarks on its next phase of expansion. 3,5-dinitro-4-chlorobenzoic acid isopropyl ester manufacturers The CHMP has agreed on an update of recommendations for monitoring patients. Healthcare professionals should now check their patients for signs of blood cancers at least once a year for 15 years.1 3,4-diamino-5-n-heptyl-1,2,4-triazole suppliers The analysis examined disease manifestations in the two most commonly impacted organ domains in SLE. Anifrolumab is a potential first-in-class type I interferon inhibitor. Boc-Tyr-Met-Gly-Trp-Met-Asp-NH2 vendor & factory.